Spondyloarthropathies
News
Shift in approach needed for managing inflammatory arthritis in pregnancy
Conference Coverage
Apremilast’s positive study results made it the talk of ACR 2013
Major finding: After 16 weeks of treatment, the investigational drug apremilast achieved an ACR20 response of 29.2% at 20 mg twice daily as first-...
Conference Coverage
Treat-to-target approach for psoriatic arthritis found beneficial
Major finding: At 48 weeks, a higher proportion of psoriatic arthritis patients in the intensive management group achieved ACR70, compared with...
Conference Coverage
Smoking has damaging impact in ankylosing spondylitis
Major finding: Smokers had a 5.5-fold higher effect of inflammation on x-ray damage, compared with nonsmokers, and male smokers had a 13.4-fold...
News
Ustekinumab approved for psoriatic arthritis
News
Proposed axial spondyloarthritis indication for certolizumab divides FDA panel
News
FDA panel votes against new AS indication for TNF-blocker
Conference Coverage
Serum biomarker predicts radiographic progression in spondyloarthritis
Major finding: Baseline serum VEGF levels were 562 plus or minus 357 pg/mL vs.
Conference Coverage
Expert panel sets broad SpA treat-to-target goals
Conference Coverage
Spinal MRI does not enhance spondyloarthropathy diagnosis
Major finding: More than 25% of patients with nonradiographic axial spondyloarthritis who had a negative MRI scan of the sacroiliac joints (SIJs)...